{
    "clinical_study": {
        "@rank": "80724", 
        "arm_group": [
            {
                "arm_group_label": "ultrasound", 
                "arm_group_type": "Experimental", 
                "description": "ultrasound : a frequency of 1 megahertz and with an intensity of 1 W/cm2"
            }, 
            {
                "arm_group_label": "pulsed ultrasound", 
                "arm_group_type": "Experimental", 
                "description": "pulsed ultrasound : a frequency of 1 megahertz and with an intensity of 1 W/cm2 and a pulsed mode duty cycle of 1:4"
            }, 
            {
                "arm_group_label": "placebo ultrasound", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo ultrasound : same ultrasound device as described above seemed to be working but without delivering any output"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this placebo-controlled study was to evaluate the effects of pulsed and\n      continuous ultrasound treatments combined with splint therapy on patients with mild and\n      moderate idiopathic carpal tunnel syndrome"
        }, 
        "brief_title": "Continuous And Pulsed Ultrasound Treatments On Carpal Tunnel Syndrome", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Carpal Tunnel Syndrome", 
        "condition_browse": {
            "mesh_term": "Carpal Tunnel Syndrome"
        }, 
        "detailed_description": {
            "textblock": "The study included 36 carpal tunnel syndrome patients who were randomly divided into 3\n      groups.The first group received 0 W/cm2 placebo ultrasound treatment. second group received\n      1.0 W/cm2 continuous ultrasound  treatment and the third group received 1.0 W/cm2 1:4 pulsed\n      ultrasound  treatment 5 days a week for a total of 15 sessions. All patients were also\n      treated with night splints during the treatment. Pretreatment and posttreatment Visual\n      Analogue Scale scores, Symptom Severity Scale  scores, Functional Status Scale  scores,\n      median nerve motor conduction velocity. and distal latency and sensory conduction velocity\n      of median nerve in the 2nd finger and palm were compared."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Mild or moderate idiopathic carpal tunnel syndrome (without thenar atrophy or\n             spontaneous activity on electrophysiological examination of the abductor pollicis\n             brevis (APB) muscle)\n\n        Exclusion Criteria:\n\n          -  Secondary entrapment neuropathies\n\n          -  Cervical radiculopathy\n\n          -  Systemic diseases with increased risk of the carpal tunnel syndrome\n\n          -  Gained surgical relief of the syndrome\n\n          -  Treated with ultrasound for the syndrome\n\n          -  A history of steroid injections into the carpal tunnel and of physical therapy within\n             the last 3 months\n\n          -  Patients with either thenar atrophy or spontaneous activity (fibrillation potentials\n             and positive sharp waves) on electrophysiological examination"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "46", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02054247", 
            "org_study_id": "clinics-2013-0627"
        }, 
        "intervention": [
            {
                "arm_group_label": "ultrasound", 
                "description": "a frequency of 1 megahertz and with an intensity of 1 W/cm2,  5 days a week for a total of 15 sessions", 
                "intervention_name": "ultrasound", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "pulsed ultrasound", 
                "description": "a frequency of 1 megahertz and with an intensity of 1 W/cm2 and a pulsed mode duty cycle of 1:4,  5 days a week for a total of 15 sessions", 
                "intervention_name": "pulsed ultrasound", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "placebo ultrasound", 
                "description": "same ultrasound device as described above seemed to be working but without delivering any output,  5 days a week for a total of 15 sessions", 
                "intervention_name": "placebo ultrasound", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Carpal tunnel syndrome,ultrasound,pulsed ultrasound", 
        "lastchanged_date": "February 3, 2014", 
        "number_of_arms": "3", 
        "official_title": "The Placebo-Controlled Continuous And Pulsed Ultrasound Treatments on Carpal Tunnel Syndrome : A Randomised Trial", 
        "overall_official": {
            "affiliation": "Eskisehir Osmangazi University", 
            "last_name": "Onur ARMAGAN, ass. prof.", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in symptom severity with Symptom Severity Scale", 
            "safety_issue": "No", 
            "time_frame": "three weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02054247"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Eskisehir Osmangazi University", 
            "investigator_full_name": "Onur Arma\u011fan", 
            "investigator_title": "Onur Armagan MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in pain with Visual Analogue Scale", 
                "safety_issue": "No", 
                "time_frame": "Three weeks"
            }, 
            {
                "measure": "Change from baseline in functional status with Functional Status Scale", 
                "safety_issue": "No", 
                "time_frame": "Three weeks"
            }, 
            {
                "measure": "Chances from baseline median nerve motor and sensory conduction velocity and distal latencies", 
                "safety_issue": "No", 
                "time_frame": "Three weeks"
            }
        ], 
        "source": "Eskisehir Osmangazi University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Eskisehir Osmangazi University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}